Assessment of the anti-inflammatory and anti-glycemic properties of Royal Jelly and Tocotrienol-rich fraction in an experimental study: Does irisin mediate these effects?
- PMID: 39479712
- PMCID: PMC11521737
- DOI: 10.1002/fsn3.4321
Assessment of the anti-inflammatory and anti-glycemic properties of Royal Jelly and Tocotrienol-rich fraction in an experimental study: Does irisin mediate these effects?
Abstract
Irisin, a novel adipomyokine, has been proposed to be a therapeutic agent against obesity-related metabolic disease. Royal Jelly (RJ) and tocotrienol-rich fraction (TRF) are suggested to promote obesity and its related problems through potential mutual mechanistic pathways. This investigation intended to evaluate the glycemic and inflammation-promoting effects of RJ, TRF, and their combinations to evaluate their synergic effects through irisin action in obese rats induced by a high-fat diet (HFD) that underwent a calorie restriction diet (CRD). Fifty HFD-fed obese rats received the following interventions: RJ, TRF, or RJ + TRF in combination with a CRD for eight consecutive weeks. After the investigation, body weight, fasting blood sugar (FBS), irisin, insulin, C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), leptin, adiponectin, and insulin resistance (IR) were assessed. After 8 weeks of treatment, significant weight reduction was noticed in rats that received RJ and RJ + TRF related to the CRD rats (p < .001), although this reduction was not considerable in TRF-treated rats. RJ and RJ + TRF supplementation markedly elevated irisin concentrations in CRD rats (p < .05), but TRF did not. Glycemic indices, inflammatory indices including IL-1β and CRP levels, and leptin concentrations were significantly decreased after RJ, TRF, and their combinations were added to CRD (p < .05). According to the mediational analysis results, irisin mediated the promoting effects of RJ on glycemic hemostasis. Based on the results of this investigation, RJ and TRF are novel nutrients that have the potential to improve obesity-related disorders. This research suggests that RJ exerts its beneficial glycemic regulatory effects through irisin.
Keywords: Royal Jelly; glucose hemostasis; inflammation; irisin; obesity; tocotrienol‐rich fraction.
© 2024 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
The effects of royal jelly and tocotrienol-rich fraction on impaired glycemic control and inflammation through irisin in obese rats.J Food Biochem. 2020 Dec;44(12):e13493. doi: 10.1111/jfbc.13493. Epub 2020 Oct 5. J Food Biochem. 2020. PMID: 33020956
-
Effects of Royal Jelly and Tocotrienol Rich Fraction in obesity treatment of calorie-restricted obese rats: a focus on white fat browning properties and thermogenic capacity.Nutr Metab (Lond). 2020 Jun 1;17:42. doi: 10.1186/s12986-020-00458-8. eCollection 2020. Nutr Metab (Lond). 2020. PMID: 32508963 Free PMC article.
-
The effect of royal jelly and tocotrienol-rich fraction along with calorie restriction on hypothalamic endoplasmic reticulum stress and adipose tissue inflammation in diet-induced obese rats.BMC Res Notes. 2020 Aug 31;13(1):409. doi: 10.1186/s13104-020-05258-0. BMC Res Notes. 2020. PMID: 32867829 Free PMC article.
-
Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review.Nutrients. 2020 Feb 18;12(2):521. doi: 10.3390/nu12020521. Nutrients. 2020. PMID: 32085610 Free PMC article.
-
Royal Jelly: Biological Action and Health Benefits.Int J Mol Sci. 2024 May 30;25(11):6023. doi: 10.3390/ijms25116023. Int J Mol Sci. 2024. PMID: 38892209 Free PMC article. Review.
References
-
- Almeer, R. S. , Alarifi, S. , Alkahtani, S. , Ibrahim, S. R. , Ali, D. , & Moneim, A. (2018). The potential hepatoprotective effect of royal jelly against cadmium chloride‐induced hepatotoxicity in mice is mediated by suppression of oxidative stress and upregulation of Nrf2 expression. Biomedicine & Pharmacotherapy, 106, 1490–1498. - PubMed
-
- Baron, R. M. , & Kenny, D. A. (1986). The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous